Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy

被引：9
作者：
Lau, GKK [1 ]
Lie, A [1 ]
Liang, R [1 ]
机构：
[1] Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2002年 / 100卷 / 08期
关键词：
D O I：
10.1182/blood-2002-07-1976
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3054 / 3054
页数：1
相关论文
共 14 条
  • [1] COLLOREDO MG, 1993, ARCH VIROL S, V8, P203
  • [2] KASPA RT, 1986, P NATL ACAD SCI USA, V83, P1627
  • [3] Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
    Lau, GKK
    Liang, R
    Wu, PC
    Lee, CK
    Lim, WL
    Au, WY
    [J]. JOURNAL OF HEPATOLOGY, 1998, 28 (03) : 359 - 368
  • [4] High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation
    Lau, GKK
    Leung, YH
    Fong, DYT
    Au, WY
    Kwong, YL
    Lie, A
    Hou, JL
    Wen, YM
    Nanj, A
    Liang, R
    [J]. BLOOD, 2002, 99 (07) : 2324 - 2330
  • [5] Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: A review of the problem
    Liang, R
    Lau, GKK
    Kwong, YL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 394 - 398
  • [6] Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers
    Shibolet, O
    Ilan, Y
    Gillis, S
    Hubert, A
    Shouval, D
    Safadi, R
    [J]. BLOOD, 2002, 100 (02) : 391 - 396
  • [7] Steinberg JL, 2000, J MED VIROL, V60, P249, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt
  • [8] 249::AID-JMV1&gt
  • [9] 3.0.CO
  • [10] 2-C
12